Human RuvB-Like 1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human RuvB-Like 1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human RuvB-Like 1 |
| Clone | [PAT1D6AT] |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2a k |
| Format | Protein A purified |
| Size | 0.005 mg, 0.02 mg, 0.1 mg |
| Concentration | n/a |
| Applications | ELISA (EIA), Western Blot (WB), Flow Cytometry (FC/FACS), Immunocytochemistry (ICC), Immunofluorescence (IF) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | RUVBL1 is part of NuA4 histone acetyltransferase complex which participates in transcriptional activation of specific genes mainly by acetylation of nucleosomal histone H4 and H2A. This complex is essential for the activation of transcriptional programs associated with oncogene and proto oncogene mediated growth induction, tumor suppressor mediated growth arrest. |
| Immunogen | Immunogen: Anti-human RUVBL1 mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human RUVBL1 amino acids 1-456 purified from E Coli. |
| Other Names | [RUVBL1; ECP54; RUVBL1; INO80H; NMP238; PONTIN; Pontin52; RVB1; TIH1; TIP49; TIP49A; RuvB-Like 1; EC 3.6.4.12; TIP60-associated protein 54-alpha; TAP54-alpha; RuvB-Like 1, Mouse Human], [Ruvbl1; Ruvbl1; NMP238; Tip49a; Pontin52; Tip49; Tip49a; 49 kDa TBP-interacting protein] |
| Gene, Accession # | [RUVBL1], Gene ID: 65137, NCBI: NP_671706.1, UniProt: P60123 |
| Catalog # | MBS146681 |
| Price | $140, $205, $505 |
| Order / More Info | Human RuvB-Like 1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies